Why Is Intel Struggling Against AMD?
Due to its disappointing reports, so-so management, and lack of…
Buy
55
STE Quote, Financials, Valuation and Earnings
Last price:
$223.89
Seasonality move
:
6.05%
Day range:
$220.15 - $223.48
52-week range:
$200.41 - $248.24
Dividend yield:
1%
P/E ratio:
47.30x
P/S ratio:
4.10x
P/B ratio:
3.41x
Volume:
297.2K
Avg. volume:
577.7K
1-year change:
10.89%
Market cap:
$21.9B
Revenue:
$5.1B
EPS (TTM):
$4.71
Analysts' Opinion
-
Consensus RatingSteris PLC has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $250.11, Steris PLC has an estimated upside of 12.27% from its current price of $222.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $230.00 representing -3.25% downside risk from its current price of $222.77.
Fair Value
-
According to the consensus of 7 analysts, Steris PLC has 12.27% upside to fair value with a price target of $250.11 per share.
STE vs. S&P 500
-
Over the past 5 trading days, Steris PLC has underperformed the S&P 500 by -0.65% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Steris PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Steris PLC has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Steris PLC reported revenues of $1.4B.
Earnings Growth
-
Steris PLC has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Steris PLC reported earnings per share of $1.75.
Enterprise value:
23.9B
EV / Invested capital:
--
Price / LTM sales:
4.10x
EV / EBIT:
26.72x
EV / Revenue:
4.43x
PEG ratio (5yr expected):
0.26x
EV / Free cash flow:
31.82x
Price / Operating cash flow:
29.42x
Enterprise value / EBITDA:
17.29x
Gross Profit (TTM):
$2.3B
Return On Assets:
4.42%
Net Income Margin (TTM):
8.66%
Return On Equity:
7.27%
Return On Invested Capital:
5.15%
Operating Margin:
18.06%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $4.4B | $4.7B | $5.4B | $1.3B | $1.4B | |
| Gross Profit | $2B | $2B | $2.3B | $560M | $610.3M | |
| Operating Income | $677.6M | $873.9M | $927.6M | $226.5M | $247.5M | |
| EBITDA | $832.7M | $1.9B | $1.4B | $369.2M | $373.8M | |
| Diluted EPS | -$0.29 | $5.71 | $4.71 | $1.42 | $1.75 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.2B | $1.9B | $2B | $2.2B | $1.9B | |
| Total Assets | $6.6B | $11.7B | $10.8B | $11.4B | $10B | |
| Current Liabilities | $505.9M | $904.3M | $796.5M | $913.7M | $891.1M | |
| Total Liabilities | $2.7B | $5.1B | $4.8B | $5B | $3.6B | |
| Total Equity | $3.9B | $6.6B | $6B | $6.4B | $6.4B | |
| Total Debt | $1.7B | $3.3B | $3.1B | $3.3B | $2.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $712.9M | $934.3M | $1.1B | $291.2M | $332.8M | |
| Cash From Investing | -$212.2M | -$869.3M | $363M | -$118.9M | -$123.9M | |
| Cash From Financing | -$581.4M | -$133.4M | -$1.5B | -$198M | -$214.4M | |
| Free Cash Flow | $349.3M | $594M | $751.4M | $172.3M | $243.6M | |
STE
Sector
Market Cap
$21.9B
$34.9M
Price % of 52-Week High
89.74%
42.85%
Dividend Yield
1%
0%
Shareholder Yield
3.37%
-0.82%
1-Year Price Total Return
10.89%
-40.42%
Beta (5-Year)
0.873
0.738
Dividend yield:
1%
Annualized payout:
$2.03
Payout ratio:
46.04%
Growth streak:
13 years
Technicals
8-day SMA
Buy
Level
$220.88
200-day SMA
Sell
Level
$224.11
Bollinger Bands (100)
Buy
Level
210.76 - 224.82
Chaikin Money Flow
Buy
Level
145.1M
20-day SMA
Buy
Level
$220.87
Relative Strength Index (RSI14)
Buy
Level
51.61
ADX Line
Sell
Level
17.52
Williams %R
Neutral
Level
-25.8814
50-day SMA
Buy
Level
$222.66
MACD (12, 26)
Sell
Level
-0.52
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Neutral
Level
112.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.0006)
Buy
CA Score
(Annual)
Level (0.3693)
Buy
Beneish M-Score
(Annual)
Level (-2.682)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.9054)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Stock Forecast FAQ
In the current month, STE has received 3 Buy ratings 4 Hold ratings, and 0 Sell ratings. The STE average analyst price target in the past 3 months is $250.11.
-
Where Will Steris PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Steris PLC share price will rise to $250.11 per share over the next 12 months.
-
What Do Analysts Say About Steris PLC?
Analysts are divided on their view about Steris PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Steris PLC is a Sell and believe this share price will drop from its current level to $230.00.
-
What Is Steris PLC's Price Target?
The price target for Steris PLC over the next 1-year time period is forecast to be $250.11 according to 7 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is STE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Steris PLC is a Hold. 4 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of STE?
You can purchase shares of Steris PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Steris PLC shares.
-
What Is The Steris PLC Share Price Today?
Steris PLC was last trading at $223.89 per share. This represents the most recent stock quote for Steris PLC. Yesterday, Steris PLC closed at $222.77 per share.
-
How To Buy Steris PLC Stock Online?
In order to purchase Steris PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will PayPal Stock Recover or Keep Sliding?
Payments platform behemoth PayPal Holdings, Inc. (NASDAQ:PYPL) is going through…
How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 34x
Alerts
Buy
56
ROOT alert for Apr 23
Root [ROOT] is up 9.37% over the past day.
Buy
72
EFX alert for Apr 23
Equifax [EFX] is up 1.69% over the past day.
Buy
51
CALX alert for Apr 23
Calix [CALX] is down 1.81% over the past day.
